Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

WCLC 2021: KRAS drugs may do best in tough subtype

Feb. 2, 2021

Updated results presented from TRIDENT-1 study of repotrectinib

Feb. 2, 2021

Mobocertinib shows clinical benefit in patients with exon 20-mutated NSCLC

Feb. 2, 2021

Sun Pharma Advanced Research describes new camptothecin derivative prodrugs

Feb. 2, 2021

Allinky Biopharma presents GTPase KRas inhibitors

Feb. 1, 2021

New galectin-1/galectin-3 inhibitors identified at Galecto Biotech

Feb. 1, 2021

INCB-001158 plus chemotherapy shows promise for treating advanced biliary tract cancer

Feb. 1, 2021

Medshine Discovery patents multitargeted inhibitors of IRAK-4 and BTK

Feb. 1, 2021

New MAP4K1 inhibitors discovered at Guangdong Newopp Biopharmaceuticals

Feb. 1, 2021

Nanjing Zhengxiang Pharmaceuticals divulges new MAP4K1 inhibitors

Feb. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...